家庭透析:改善全球肾脏病预后组织(KDIGO)争议会议结论
2021年5月KDIGO召开家庭透析争议会议,聚焦透析方式选择与分布的决定因素及扩大家庭透析使用的策略。与会者认为家庭透析使用率低的原因因背景而异,临床结局在各透析方式间大体相似,但特定指标上某方式可能占优,故选择应基于偏好敏感的共同决策。
要点
- 家庭透析(家庭血液透析和腹膜透析)与更高的患者自主性和治疗满意度相关,但全球使用率低。
- 扩大家庭透析使用需政策、财政资源、组织结构、提供者激励和问责制相协调。
- 所有透析方式临床结局大体相似,但特定临床指标上某方式可能占优,选择应偏好敏感。
核心结论
- 家庭透析与更高的患者自主性和治疗满意度相关,但全球使用水平低。
- 扩大家庭透析使用需要在卫生系统内政策、财政资源、组织结构、提供者激励和问责制相协调。
- 所有透析方式的临床结局大体相似,但特定临床指标上某方式可能占优,故选择应偏好敏感。
- 理想情况下,个体、照护伙伴和医疗团队应在评估初始和后续肾衰竭治疗选项时采用共同决策。
- 每位面临透析的人都应能获得家庭治疗,促进普遍可及和扩大使用需要透析中心层面的政策考虑和资源协调,以及由知情且积极的临床团队提供明确领导。
研究设计与样本
- 2021年5月,KDIGO召开家庭透析争议会议。
主要发现
- 家庭透析使用有限的原因因背景而异,受当地资源、透析费用、医疗可及性、卫生系统政策、提供者偏倚或偏好、文化信仰、个人生活方式顾虑、潜在照护伙伴时间和经济负担影响。
- 扩大特定卫生系统内家庭透析使用需要政策、财政资源、组织结构、提供者激励和问责制相协调。
- 所有透析方式的临床结局大体相似,但特定临床指标上某方式可能占优。
- 选择可用方式应偏好敏感,考虑生活质量、生活目标、临床特征、家庭或照护伙伴支持以及居住环境。
- 为达目标,对医疗专业人员、患者和照护伙伴进行迭代高质量教育和支持是优先事项。
临床怎么用
- 个体、照护伙伴和医疗团队应在评估初始和后续肾衰竭治疗选项时采用共同决策。
- 每位面临透析的人都应能获得家庭治疗。
- 促进家庭透析普遍可及和扩大使用需要透析中心层面的政策考虑和资源协调,并由知情且积极的临床团队提供明确领导。
- 对医疗专业人员、患者和照护伙伴进行迭代高质量教育和支持是优先事项。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Home dialysis modalities (home hemodialysis [HD] and peritoneal dialysis [PD]) are associated with greater patient autonomy and treatment satisfaction compared with in-center modalities, yet the level of home-dialysis use worldwide is low. Reasons for limited utilization are context-dependent, informed by local resources, dialysis costs, access to healthcare, health system policies, provider bias or preferences, cultural beliefs, individual lifestyle concerns, potential care-partner time, and financial burdens. In May 2021, KDIGO (Kidney Disease: Improving Global Outcomes) convened a controversies conference on home dialysis, focusing on how modality choice and distribution are determined and strategies to expand home-dialysis use. Participants recognized that expanding use of home dialysis within a given health system requires alignment of policy, fiscal resources, organizational structure, provider incentives, and accountability. Clinical outcomes across all dialysis modalities are largely similar, but for specific clinical measures, one modality may have advantages over another. Therefore, choice among available modalities is preference-sensitive, with consideration of quality of life, life goals, clinical characteristics, family or care-partner support, and living environment. Ideally, individuals, their care-partners, and their healthcare teams will employ shared decision-making in assessing initial and subsequent kidney failure treatment options. To meet this goal, iterative, high-quality education and support for healthcare professionals, patients, and care-partners are priorities. Everyone who faces dialysis should have access to home therapy. Facilitating universal access to home dialysis and expanding utilization requires alignment of policy considerations and resources at the dialysis-center level, with clear leadership from informed and motivated clinical teams.
引用
- Perl J, Brown EA, Chan CT, et al. Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023. PMID: 36731611. doi:10.1016/j.kint.2023.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。